In the News September 10, 2019

Law360 | FDA Faces Free Speech Issues with Juul Warnings

Marc Scheineson comments on First Amendment issues surrounding the U.S. Food and Drug Administration’s crackdown on advertising by e-cigarette maker Juul.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.